The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global mRNA Platform Market Research Report 2025
Synopsis
The mRNA platform refers to a technology and method used for vaccine development and gene therapy. mRNA, or messenger RNA, is a single-stranded molecule that carries genetic information from DNA to the ribosomes in cells, where it is translated into proteins. In the mRNA platform, synthetic mRNA molecules containing the genetic code for a specific protein are delivered into cells to instruct them to produce that protein.
The global mRNA Platform market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for mRNA Platform is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for mRNA Platform is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for mRNA Platform in Infectious Disease is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of mRNA Platform include Arcturus Therapeutic, Argos Therapeutics, BioNTec, CureVac, Etherna, Ethris, GlaxoSmithKline, Pfizer and Translate Bio, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for mRNA Platform, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Platform.
Report Scope
The mRNA Platform market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global mRNA Platform market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the mRNA Platform companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Arcturus Therapeutic
Argos Therapeutics
BioNTec
CureVac
Etherna
Ethris
GlaxoSmithKline
Pfizer
Translate Bio
Segment by Type
Infectious Disease Vaccines
Cancer Vaccines
Segment by Application
Infectious Disease
Cancer
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of mRNA Platform companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The mRNA platform refers to a technology and method used for vaccine development and gene therapy. mRNA, or messenger RNA, is a single-stranded molecule that carries genetic information from DNA to the ribosomes in cells, where it is translated into proteins. In the mRNA platform, synthetic mRNA molecules containing the genetic code for a specific protein are delivered into cells to instruct them to produce that protein.
The global mRNA Platform market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for mRNA Platform is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for mRNA Platform is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for mRNA Platform in Infectious Disease is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of mRNA Platform include Arcturus Therapeutic, Argos Therapeutics, BioNTec, CureVac, Etherna, Ethris, GlaxoSmithKline, Pfizer and Translate Bio, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for mRNA Platform, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Platform.
Report Scope
The mRNA Platform market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global mRNA Platform market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the mRNA Platform companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Arcturus Therapeutic
Argos Therapeutics
BioNTec
CureVac
Etherna
Ethris
GlaxoSmithKline
Pfizer
Translate Bio
Segment by Type
Infectious Disease Vaccines
Cancer Vaccines
Segment by Application
Infectious Disease
Cancer
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of mRNA Platform companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global mRNA Platform Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Infectious Disease Vaccines
1.2.3 Cancer Vaccines
1.3 Market by Application
1.3.1 Global mRNA Platform Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Infectious Disease
1.3.3 Cancer
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global mRNA Platform Market Perspective (2019-2030)
2.2 mRNA Platform Growth Trends by Region
2.2.1 Global mRNA Platform Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 mRNA Platform Historic Market Size by Region (2019-2024)
2.2.3 mRNA Platform Forecasted Market Size by Region (2025-2030)
2.3 mRNA Platform Market Dynamics
2.3.1 mRNA Platform Industry Trends
2.3.2 mRNA Platform Market Drivers
2.3.3 mRNA Platform Market Challenges
2.3.4 mRNA Platform Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top mRNA Platform Players by Revenue
3.1.1 Global Top mRNA Platform Players by Revenue (2019-2024)
3.1.2 Global mRNA Platform Revenue Market Share by Players (2019-2024)
3.2 Global mRNA Platform Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by mRNA Platform Revenue
3.4 Global mRNA Platform Market Concentration Ratio
3.4.1 Global mRNA Platform Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by mRNA Platform Revenue in 2023
3.5 mRNA Platform Key Players Head office and Area Served
3.6 Key Players mRNA Platform Product Solution and Service
3.7 Date of Enter into mRNA Platform Market
3.8 Mergers & Acquisitions, Expansion Plans
4 mRNA Platform Breakdown Data by Type
4.1 Global mRNA Platform Historic Market Size by Type (2019-2024)
4.2 Global mRNA Platform Forecasted Market Size by Type (2025-2030)
5 mRNA Platform Breakdown Data by Application
5.1 Global mRNA Platform Historic Market Size by Application (2019-2024)
5.2 Global mRNA Platform Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America mRNA Platform Market Size (2019-2030)
6.2 North America mRNA Platform Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America mRNA Platform Market Size by Country (2019-2024)
6.4 North America mRNA Platform Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe mRNA Platform Market Size (2019-2030)
7.2 Europe mRNA Platform Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe mRNA Platform Market Size by Country (2019-2024)
7.4 Europe mRNA Platform Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific mRNA Platform Market Size (2019-2030)
8.2 Asia-Pacific mRNA Platform Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific mRNA Platform Market Size by Region (2019-2024)
8.4 Asia-Pacific mRNA Platform Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America mRNA Platform Market Size (2019-2030)
9.2 Latin America mRNA Platform Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America mRNA Platform Market Size by Country (2019-2024)
9.4 Latin America mRNA Platform Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa mRNA Platform Market Size (2019-2030)
10.2 Middle East & Africa mRNA Platform Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa mRNA Platform Market Size by Country (2019-2024)
10.4 Middle East & Africa mRNA Platform Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Arcturus Therapeutic
11.1.1 Arcturus Therapeutic Company Detail
11.1.2 Arcturus Therapeutic Business Overview
11.1.3 Arcturus Therapeutic mRNA Platform Introduction
11.1.4 Arcturus Therapeutic Revenue in mRNA Platform Business (2019-2024)
11.1.5 Arcturus Therapeutic Recent Development
11.2 Argos Therapeutics
11.2.1 Argos Therapeutics Company Detail
11.2.2 Argos Therapeutics Business Overview
11.2.3 Argos Therapeutics mRNA Platform Introduction
11.2.4 Argos Therapeutics Revenue in mRNA Platform Business (2019-2024)
11.2.5 Argos Therapeutics Recent Development
11.3 BioNTec
11.3.1 BioNTec Company Detail
11.3.2 BioNTec Business Overview
11.3.3 BioNTec mRNA Platform Introduction
11.3.4 BioNTec Revenue in mRNA Platform Business (2019-2024)
11.3.5 BioNTec Recent Development
11.4 CureVac
11.4.1 CureVac Company Detail
11.4.2 CureVac Business Overview
11.4.3 CureVac mRNA Platform Introduction
11.4.4 CureVac Revenue in mRNA Platform Business (2019-2024)
11.4.5 CureVac Recent Development
11.5 Etherna
11.5.1 Etherna Company Detail
11.5.2 Etherna Business Overview
11.5.3 Etherna mRNA Platform Introduction
11.5.4 Etherna Revenue in mRNA Platform Business (2019-2024)
11.5.5 Etherna Recent Development
11.6 Ethris
11.6.1 Ethris Company Detail
11.6.2 Ethris Business Overview
11.6.3 Ethris mRNA Platform Introduction
11.6.4 Ethris Revenue in mRNA Platform Business (2019-2024)
11.6.5 Ethris Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Detail
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline mRNA Platform Introduction
11.7.4 GlaxoSmithKline Revenue in mRNA Platform Business (2019-2024)
11.7.5 GlaxoSmithKline Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Detail
11.8.2 Pfizer Business Overview
11.8.3 Pfizer mRNA Platform Introduction
11.8.4 Pfizer Revenue in mRNA Platform Business (2019-2024)
11.8.5 Pfizer Recent Development
11.9 Translate Bio
11.9.1 Translate Bio Company Detail
11.9.2 Translate Bio Business Overview
11.9.3 Translate Bio mRNA Platform Introduction
11.9.4 Translate Bio Revenue in mRNA Platform Business (2019-2024)
11.9.5 Translate Bio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global mRNA Platform Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Infectious Disease Vaccines
Table 3. Key Players of Cancer Vaccines
Table 4. Global mRNA Platform Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global mRNA Platform Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global mRNA Platform Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global mRNA Platform Market Share by Region (2019-2024)
Table 8. Global mRNA Platform Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global mRNA Platform Market Share by Region (2025-2030)
Table 10. mRNA Platform Market Trends
Table 11. mRNA Platform Market Drivers
Table 12. mRNA Platform Market Challenges
Table 13. mRNA Platform Market Restraints
Table 14. Global mRNA Platform Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global mRNA Platform Market Share by Players (2019-2024)
Table 16. Global Top mRNA Platform Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Platform as of 2023)
Table 17. Ranking of Global Top mRNA Platform Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by mRNA Platform Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players mRNA Platform Product Solution and Service
Table 21. Date of Enter into mRNA Platform Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global mRNA Platform Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global mRNA Platform Revenue Market Share by Type (2019-2024)
Table 25. Global mRNA Platform Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global mRNA Platform Revenue Market Share by Type (2025-2030)
Table 27. Global mRNA Platform Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global mRNA Platform Revenue Market Share by Application (2019-2024)
Table 29. Global mRNA Platform Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global mRNA Platform Revenue Market Share by Application (2025-2030)
Table 31. North America mRNA Platform Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America mRNA Platform Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America mRNA Platform Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe mRNA Platform Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe mRNA Platform Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe mRNA Platform Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific mRNA Platform Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific mRNA Platform Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific mRNA Platform Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America mRNA Platform Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America mRNA Platform Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America mRNA Platform Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa mRNA Platform Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa mRNA Platform Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa mRNA Platform Market Size by Country (2025-2030) & (US$ Million)
Table 46. Arcturus Therapeutic Company Detail
Table 47. Arcturus Therapeutic Business Overview
Table 48. Arcturus Therapeutic mRNA Platform Product
Table 49. Arcturus Therapeutic Revenue in mRNA Platform Business (2019-2024) & (US$ Million)
Table 50. Arcturus Therapeutic Recent Development
Table 51. Argos Therapeutics Company Detail
Table 52. Argos Therapeutics Business Overview
Table 53. Argos Therapeutics mRNA Platform Product
Table 54. Argos Therapeutics Revenue in mRNA Platform Business (2019-2024) & (US$ Million)
Table 55. Argos Therapeutics Recent Development
Table 56. BioNTec Company Detail
Table 57. BioNTec Business Overview
Table 58. BioNTec mRNA Platform Product
Table 59. BioNTec Revenue in mRNA Platform Business (2019-2024) & (US$ Million)
Table 60. BioNTec Recent Development
Table 61. CureVac Company Detail
Table 62. CureVac Business Overview
Table 63. CureVac mRNA Platform Product
Table 64. CureVac Revenue in mRNA Platform Business (2019-2024) & (US$ Million)
Table 65. CureVac Recent Development
Table 66. Etherna Company Detail
Table 67. Etherna Business Overview
Table 68. Etherna mRNA Platform Product
Table 69. Etherna Revenue in mRNA Platform Business (2019-2024) & (US$ Million)
Table 70. Etherna Recent Development
Table 71. Ethris Company Detail
Table 72. Ethris Business Overview
Table 73. Ethris mRNA Platform Product
Table 74. Ethris Revenue in mRNA Platform Business (2019-2024) & (US$ Million)
Table 75. Ethris Recent Development
Table 76. GlaxoSmithKline Company Detail
Table 77. GlaxoSmithKline Business Overview
Table 78. GlaxoSmithKline mRNA Platform Product
Table 79. GlaxoSmithKline Revenue in mRNA Platform Business (2019-2024) & (US$ Million)
Table 80. GlaxoSmithKline Recent Development
Table 81. Pfizer Company Detail
Table 82. Pfizer Business Overview
Table 83. Pfizer mRNA Platform Product
Table 84. Pfizer Revenue in mRNA Platform Business (2019-2024) & (US$ Million)
Table 85. Pfizer Recent Development
Table 86. Translate Bio Company Detail
Table 87. Translate Bio Business Overview
Table 88. Translate Bio mRNA Platform Product
Table 89. Translate Bio Revenue in mRNA Platform Business (2019-2024) & (US$ Million)
Table 90. Translate Bio Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global mRNA Platform Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global mRNA Platform Market Share by Type: 2023 VS 2030
Figure 3. Infectious Disease Vaccines Features
Figure 4. Cancer Vaccines Features
Figure 5. Global mRNA Platform Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global mRNA Platform Market Share by Application: 2023 VS 2030
Figure 7. Infectious Disease Case Studies
Figure 8. Cancer Case Studies
Figure 9. mRNA Platform Report Years Considered
Figure 10. Global mRNA Platform Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 11. Global mRNA Platform Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global mRNA Platform Market Share by Region: 2023 VS 2030
Figure 13. Global mRNA Platform Market Share by Players in 2023
Figure 14. Global Top mRNA Platform Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Platform as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by mRNA Platform Revenue in 2023
Figure 16. North America mRNA Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. North America mRNA Platform Market Share by Country (2019-2030)
Figure 18. United States mRNA Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Canada mRNA Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Europe mRNA Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe mRNA Platform Market Share by Country (2019-2030)
Figure 22. Germany mRNA Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. France mRNA Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. U.K. mRNA Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Italy mRNA Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Russia mRNA Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Nordic Countries mRNA Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Asia-Pacific mRNA Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific mRNA Platform Market Share by Region (2019-2030)
Figure 30. China mRNA Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Japan mRNA Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. South Korea mRNA Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Southeast Asia mRNA Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. India mRNA Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Australia mRNA Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Latin America mRNA Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America mRNA Platform Market Share by Country (2019-2030)
Figure 38. Mexico mRNA Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Brazil mRNA Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa mRNA Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa mRNA Platform Market Share by Country (2019-2030)
Figure 42. Turkey mRNA Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Saudi Arabia mRNA Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Arcturus Therapeutic Revenue Growth Rate in mRNA Platform Business (2019-2024)
Figure 45. Argos Therapeutics Revenue Growth Rate in mRNA Platform Business (2019-2024)
Figure 46. BioNTec Revenue Growth Rate in mRNA Platform Business (2019-2024)
Figure 47. CureVac Revenue Growth Rate in mRNA Platform Business (2019-2024)
Figure 48. Etherna Revenue Growth Rate in mRNA Platform Business (2019-2024)
Figure 49. Ethris Revenue Growth Rate in mRNA Platform Business (2019-2024)
Figure 50. GlaxoSmithKline Revenue Growth Rate in mRNA Platform Business (2019-2024)
Figure 51. Pfizer Revenue Growth Rate in mRNA Platform Business (2019-2024)
Figure 52. Translate Bio Revenue Growth Rate in mRNA Platform Business (2019-2024)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
